Potential Eye Disorders in People With and Without Type 2 Diabetes Mellitus Exposed to GLP-1 Receptor Agonists: An Examination of the FAERS (FDA Adverse Event Reporting System) Database
These results provide a signal of increased reporting of various eye disorders with GLP-1RA use compared to metformin across T2DM and non-T2DM patient cases. Further research is required to support these findings and confirm a biological causation.
Authors
- Stefania Chiappini
- Miranda Murray (ORCID: https://orcid.org/0009-0000-6870-0941)
- John Corkery (ORCID: https://orcid.org/0000-0002-3849-817X)
- Fabrizio Schifano (ORCID: https://orcid.org/0000-0002-4178-5401)
- Amira Guirguis (ORCID: https://orcid.org/0000-0001-8255-0660)
Institutions
- University of Hertfordshire (GB)
- Singleton Hospital (GB)
- Swansea University (GB)
- Saint Camillus International University of Health and Medical Sciences (IT)
Publication Details
- Journal
- American Journal of Ophthalmology
- Published
- 2025-12-20
- DOI
- https://doi.org/10.1016/j.ajo.2025.12.015
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.59